Pharmaresearch Bio Co (XKRX:217950) Short-Term Debt : ₩31,174 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Short-Term Debt?

Pharmaresearch Bio Co's Short-Term Debt for the quarter that ended in Dec. 2024 was ₩31,174 Mil.

Pharmaresearch Bio Co's quarterly Short-Term Debt increased from Dec. 2022 (₩3,317 Mil) to Dec. 2023 (₩21,275 Mil) and increased from Dec. 2023 (₩21,275 Mil) to Dec. 2024 (₩31,174 Mil).

Pharmaresearch Bio Co's annual Short-Term Debt increased from Dec. 2022 (₩3,317 Mil) to Dec. 2023 (₩21,275 Mil) and increased from Dec. 2023 (₩21,275 Mil) to Dec. 2024 (₩31,174 Mil).

Pharmaresearch Bio Co Short-Term Debt Historical Data

The historical data trend for Pharmaresearch Bio Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Short-Term Debt Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

3,464.25

3,683.42

3,316.53

21,274.51

31,173.91

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Short-Term Debt	Get a 7-Day Free Trial			3,464.25	3,683.42	3,316.53	21,274.51	31,173.91

Pharmaresearch Bio Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Pharmaresearch Bio Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines